TipRanks
Alterity Therapeutics Ltd (ATHE)
NASDAQ:ATHE
US Market
ATHE
Alterity Therapeutics
RESEARCH TOOLSreports
Want to see ATHE full AI Analyst Report?

Alterity Therapeutics (ATHE) Stock News & Sentiment

319 Followers
Alterity Extends ATH434 Access, Reinforcing Its Bet on Rare MSA Market
Premium
Company Announcements
Alterity Extends ATH434 Access, Reinforcing Its Bet on Rare MSA Market
13d ago
ATHE
Alterity Therapeutics Reaffirmed at Buy as Pivotal Phase 3 Nears; $16 Price Target Maintained
Premium
Ratings
Alterity Therapeutics Reaffirmed at Buy as Pivotal Phase 3 Nears; $16 Price Target Maintained
1M ago
ATHE
Alterity Therapeutics Seeks Quotation of ATH Securities in August 2026
Premium
Company Announcements
Alterity Therapeutics Seeks Quotation of ATH Securities in August 2026
2M ago
6K
ATHE
Alterity Therapeutics Wins Long-Term U.S. Patent Protection for Lead MSA Drug ATH434
Premium
Company Announcements
Alterity Therapeutics Wins Long-Term U.S. Patent Protection for Lead MSA Drug ATH434
2M ago
6K
ATHE
Alterity Therapeutics Files August 3 Application to Quote ATH Securities
Premium
Company Announcements
Alterity Therapeutics Files August 3 Application to Quote ATH Securities
2M ago
6K
ATHE
Alterity Therapeutics Secures FDA Pathway and Bolsters Funding for ATH434 Phase 3 in MSA
Premium
Company Announcements
Alterity Therapeutics Secures FDA Pathway and Bolsters Funding for ATH434 Phase 3 in MSA
2M ago
6K
ATHE
Alterity Therapeutics Files Form 6-K and Seeks Quotation for ATH Securities
Premium
Company Announcements
Alterity Therapeutics Files Form 6-K and Seeks Quotation for ATH Securities
3M ago
6K
ATHE
More ATHE News >

ATHE News on the Web

Alterity Therapeutics Reaffirmed at Buy as Pivotal Phase 3 Nears; $16 Price Target Maintained
TipRanks News
Bullish
Alterity Therapeutics Seeks Quotation of ATH Securities in August 2026
TipRanks News
Neutral
Alterity Therapeutics Files August 3 Application to Quote ATH Securities
TipRanks News
Neutral
Alterity Therapeutics Files Form 6-K and Seeks Quotation for ATH Securities
TipRanks News
Neutral
Alterity Therapeutics CEO to Engage U.S. Investors at BTIG Biotechnology Conference 2026
TipRanks News
Neutral
Analysts Are Bullish on These Healthcare Stocks: Alterity Therapeutics (ATHE), Vera Therapeutics (VERA)
TipRanks News
Bullish
Alterity Therapeutics (ATHE) Faces 8.8% Decline Ahead of Market Open
GuruFocus News
Bearish
Alterity Therapeutics receives FDA meeting minutes on pathway for ATH434
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
ATHE
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATHE’s Media Buzz Sentiment?
1 articles about ATHE were published this week. In an average week, 1 articles are published.
    What is ATHE’s weekly average amount of articles?
    In an average week, 1 articles about ATHE are published.
      What is ATHE’s News Sentiment?
      100% of articles about ATHE were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        BAYRYBayer
        ABTAbbott Laboratories
        INCYIncyte
        SMMTSummit Therapeutics
        CRVOCervoMed
        Showing the stocks with the most bullish news sentiment over the past week